Dose reduction in maxillofacial imaging using low dose Cone Beam CT

Objectives: (a) To measure the absorbed dose at certain anatomical sites of a RANDO phantom and to estimate the effective dose in radiographic imaging of the jaws using low dose Cone Beam computed tomography (CBCT) and (b) to compare the absorbed and the effective doses between thyroid and cervical spine shielding and non-shielding techniques. Study design: Thermoluminescent dosimeters (TLD-100) were placed at 14 sites in a RANDO phantom. using a Cone Beam CT device (Newtom, Model QR-DVT 9000, Verona, Italy). Dosimetry was carried out applying two techniques: in the first. there was no shielding device used while in the second one, a shielding device (EUREKA!, TRLX) was applied for protection of the thyroid gland and the cervical spine. Effective dose was estimated according to ICRP60 report (E-ICRP). An additional estimation of the effective dose was accomplished including the doses of the salivary glands (E-SAL). A Wilcoxon Signed Ranks Test was used for statistical analysis. Results: In the non-shielding technique the absorbed doses ranged from 0.16 to 1.67 mGy, while 0.32 and 1.28 mGy were the doses to the thyroid and the cervical spine, respectively. The effective dose, E-ICRP, was 0.035 mSv and the E-SAL was 0.064 mSv. In the shielding technique, the absorbed doses ranged from 0.09 to 1.64 mGy, while 0.18 and 0.95 mGy were the respective values for the thyroid and the cervical spine. The effective dose, E-ICRP, was 0.023 mSv and E-SAL was 0.052 mSv. Conclusions: The use of CBCT for maxillofacial imaging results in a reduced absorbed and effective dose. The use of lead shielding leads to a further reduction of the absorbed doses of thyroid and cervical spine, as well as the effective dose. (C) 2005 Elsevier Ireland Ltd. All rights reserved.